New On-Demand Webinar: Applying IsoPSA's Predictive Power to Guide Patient Monitoring   View On-Demand

CME Credit

Discover how cutting-edge ancillary testing is transforming prostate cancer diagnosis and risk assessment.

burst cme guiding prostate cancer diagnosis with biomarker testing
Continuing Medical Education

Incorporating Multiparametric MRI to Guide Prostate Cancer Diagnosis

Faculty: Stacy Loeb, MD, MSc, PhD (Hon), Professor of Urology and Population Health, New York University Langone Health

This educational activity is directed toward urologists. Primary care physicians, nurse practitioners, physician assistants, and other health care professionals involved in screening and diagnosing patients for prostate cancer are invited to participate as well.

Learning Objectives

 

Upon successful completion of this activity, you should be better prepared to:

  • Integrate biomarker testing and magnetic resonance imaging to improve risk stratification and early detection in patients with a high risk of prostate cancer

 

 

Unlock your CME course

Subscribe for More CME Opportunities

Interested in earning additional CME credits and accessing upcoming educational resources, webinars, and case studies? Subscribe to the IsoPSA email list to receive updates on future programs.